№67 / Д. Воробьева

Литература

  1. Reynolds R. V., Yeung H., Cheng C. E., Cook-Bolden F., et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024, № 90(5): 1006.e1-1006.e30.
  2. Hornsey S., Stuart B., Muller I., et al. Patient-reported outcome measures for acne: a mixed-methods validation study (acne PROMs). BMJ. 2021, № 11: e034047.
  3. Schachner L. A., Alexis A. F., Andriessen A., Berson D., et al. Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide-containing skincare. J Cosmet Dermatol. 2023, № 22(11): 2902-2909.
  4. Sukanjanapong S., Ploydaeng M., Wattanakrai P. Skin barrier parameters in acne vulgaris versus normal controls: a cross-sectional analytic study. Clin Cosmet Investig Dermatol. 2024, № 17: 2427-2436.
  5. Cho E., Kim M. H. Exploring the potential therapeutic effects of quantum molecular resonance for managing mild acne. J Cosmet Dermatol. 2024, № 23(6): 2295-2297.
  6. Kim J., Deshar B., Hwang M., Shrestha C., et al. Quantum molecular resonance ameliorates atopic dermatitis through suppression of IL36G and SPRR2B. BMB. 2025, № 58(5): 209-216.
  7. Ballesteros-Sánchez A., Sánchez-González J. M., Tedesco G. R., Rocha-De-Lossada C., et al. Efficacy and safety of quantum molecular resonance electrotherapy in patients with aqueous-deficient, evaporative and mixed-type dry eye: a randomized interventional study. Ophthalmol Ther. 2024, № 13(2): 495-507.